PETER MUELLER Insider Trading Transactions
Get free email notifications about insider trading for PETER MUELLER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PETER MUELLER. PETER MUELLER is CSO & EVP Drug Innovation in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and CSO & SVP Drug Discovery in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and CSO&EVP Drug Innov&Realization in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP Drug Disc., Innov & Realiz in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP Drug Innov.& Realiz, CSO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP Global R&D, CSO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP, Global R&D, CSO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in BioXcel Therapeutics, Inc. ($BTAI).
Latest Insider Trading Transactions of PETER MUELLER
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 26 2020 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Option Exercise | A | 49.74 | 5,000 | 248,700 | 5,000 | |
May 26 2020 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Option Exercise | A | 49.74 | 20,000 | 994,800 | 20,000 | |
Aug 26 2019 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 9.34 | 1,554 | 14,514 | 168,320 | 166.8 K to 168.3 K (+0.93 %) |
Aug 23 2019 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 8.83 | 6,646 | 58,684 | 166,766 | 160.1 K to 166.8 K (+4.15 %) |
Aug 23 2019 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 8.42 | 1,800 | 15,156 | 160,120 | 158.3 K to 160.1 K (+1.14 %) |
May 28 2019 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Option Exercise | A | 10.04 | 14,700 | 147,588 | 14,700 | |
Dec 07 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 5.01 | 6,905 | 34,594 | 158,320 | 151.4 K to 158.3 K (+4.56 %) |
Dec 07 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 5.00 | 495 | 2,475 | 151,415 | 150.9 K to 151.4 K (+0.33 %) |
Dec 07 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 5.01 | 100 | 501 | 150,920 | 150.8 K to 150.9 K (+0.07 %) |
Dec 07 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 5.00 | 1,295 | 6,475 | 150,820 | 149.5 K to 150.8 K (+0.87 %) |
Dec 06 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 5.15 | 2,062 | 10,619 | 149,525 | 147.5 K to 149.5 K (+1.40 %) |
Dec 06 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 5.13 | 200 | 1,026 | 147,463 | 147.3 K to 147.5 K (+0.14 %) |
Dec 06 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 5.12 | 344 | 1,761 | 147,263 | 146.9 K to 147.3 K (+0.23 %) |
Dec 06 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 5.11 | 325 | 1,661 | 146,919 | 146.6 K to 146.9 K (+0.22 %) |
Dec 06 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 5.09 | 1,076 | 5,477 | 146,594 | 145.5 K to 146.6 K (+0.74 %) |
Mar 13 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Option Exercise | A | 11.00 | 37,209 | 409,299 | 161,397 | |
Feb 07 2011 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Option Exercise | A | 38.80 | 72,500 | 2,813,000 | 72,500 | |
Feb 07 2011 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Grant | A | 0.01 | 14,501 | 145 | 133,735 | 119.2 K to 133.7 K (+12.16 %) |
Nov 16 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Option Exercise | M | 10.41 | 1,600 | 16,656 | 16,800 | |
Nov 16 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 34.43 | 1,600 | 55,088 | 119,234 | 120.8 K to 119.2 K (-1.32 %) |
Nov 16 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Buy | M | 10.41 | 1,600 | 16,656 | 120,834 | 119.2 K to 120.8 K (+1.34 %) |
Oct 18 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Option Exercise | M | 10.41 | 1,600 | 16,656 | 18,400 | |
Oct 18 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 36.02 | 330 | 11,887 | 119,234 | 119.6 K to 119.2 K (-0.28 %) |
Oct 18 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 35.55 | 1,270 | 45,149 | 119,564 | 120.8 K to 119.6 K (-1.05 %) |
Oct 18 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Buy | M | 10.41 | 1,600 | 16,656 | 120,834 | 119.2 K to 120.8 K (+1.34 %) |
Sep 16 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Option Exercise | M | 10.41 | 1,600 | 16,656 | 20,000 | |
Sep 16 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 37.22 | 1,600 | 59,552 | 119,234 | 120.8 K to 119.2 K (-1.32 %) |
Sep 16 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Buy | M | 10.41 | 1,600 | 16,656 | 120,834 | 119.2 K to 120.8 K (+1.34 %) |
Aug 17 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Option Exercise | M | 10.41 | 1,600 | 16,656 | 21,600 | |
Aug 17 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 36.38 | 1,600 | 58,208 | 119,234 | 120.8 K to 119.2 K (-1.32 %) |
Aug 17 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Buy | M | 10.41 | 1,600 | 16,656 | 120,834 | 119.2 K to 120.8 K (+1.34 %) |
Jul 16 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Option Exercise | A | 33.82 | 36,250 | 1,225,975 | 36,250 | |
Jul 16 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Option Exercise | M | 10.41 | 1,600 | 16,656 | 23,200 | |
Jul 16 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 34.24 | 1,600 | 54,784 | 119,234 | 120.8 K to 119.2 K (-1.32 %) |
Jul 16 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Buy | M | 10.41 | 1,600 | 16,656 | 120,834 | 119.2 K to 120.8 K (+1.34 %) |
Jun 16 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Option Exercise | M | 10.41 | 1,600 | 16,656 | 24,800 | |
Jun 16 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 34.93 | 1,600 | 55,888 | 119,234 | 120.8 K to 119.2 K (-1.32 %) |
Jun 16 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Buy | M | 10.41 | 1,600 | 16,656 | 120,834 | 119.2 K to 120.8 K (+1.34 %) |
May 18 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Option Exercise | M | 10.41 | 1,600 | 16,656 | 26,400 | |
May 18 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 37.39 | 1,600 | 59,824 | 119,234 | 120.8 K to 119.2 K (-1.32 %) |
May 18 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Buy | M | 10.41 | 1,600 | 16,656 | 120,834 | 119.2 K to 120.8 K (+1.34 %) |
May 10 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 36.18 | 2,987 | 108,070 | 119,234 | 122.2 K to 119.2 K (-2.44 %) |
May 10 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 35.78 | 3,284 | 117,502 | 122,221 | 125.5 K to 122.2 K (-2.62 %) |
Apr 16 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Option Exercise | M | 10.41 | 1,600 | 16,656 | 28,000 | |
Apr 16 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 39.61 | 1,600 | 63,376 | 125,505 | 127.1 K to 125.5 K (-1.26 %) |
Apr 16 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Buy | M | 10.41 | 1,600 | 16,656 | 127,105 | 125.5 K to 127.1 K (+1.27 %) |
Mar 16 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Option Exercise | M | 10.41 | 1,600 | 16,656 | 29,600 | |
Mar 16 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 43.08 | 1,600 | 68,928 | 125,505 | 127.1 K to 125.5 K (-1.26 %) |
Mar 16 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Buy | M | 10.41 | 1,600 | 16,656 | 127,105 | 125.5 K to 127.1 K (+1.27 %) |
Feb 18 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Option Exercise | M | 10.41 | 1,600 | 16,656 | 3,120 | |
Feb 18 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 38.55 | 1,600 | 61,680 | 125,505 | 127.1 K to 125.5 K (-1.26 %) |
Feb 18 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Buy | M | 10.41 | 1,600 | 16,656 | 127,105 | 125.5 K to 127.1 K (+1.27 %) |
Feb 08 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Option Exercise | A | 39.05 | 108,750 | 4,246,688 | 108,750 | |
Feb 08 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Grant | A | 0.01 | 14,501 | 145 | 125,505 | 111 K to 125.5 K (+13.06 %) |
Feb 04 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 40.07 | 3,844 | 154,029 | 111,004 | 114.8 K to 111 K (-3.35 %) |
Jan 27 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 39.39 | 2,026 | 79,804 | 114,848 | 116.9 K to 114.8 K (-1.73 %) |
Jan 19 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Global R&D, CSO | Option Exercise | M | 10.41 | 1,600 | 16,656 | 32,800 | |
Jan 19 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Global R&D, CSO | Sell | S | 41.34 | 300 | 12,402 | 116,874 | 117.2 K to 116.9 K (-0.26 %) |
Jan 19 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Global R&D, CSO | Sell | S | 40.09 | 1,300 | 52,117 | 117,174 | 118.5 K to 117.2 K (-1.10 %) |
Jan 19 2010 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Global R&D, CSO | Buy | M | 10.41 | 1,600 | 16,656 | 118,474 | 116.9 K to 118.5 K (+1.37 %) |
Dec 09 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Global R&D, CSO | Option Exercise | M | 10.41 | 1,600 | 16,656 | 34,400 | |
Dec 09 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Global R&D, CSO | Sell | S | 39.62 | 1,600 | 63,392 | 116,874 | 118.5 K to 116.9 K (-1.35 %) |
Dec 09 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Global R&D, CSO | Buy | M | 10.41 | 1,600 | 16,656 | 118,474 | 116.9 K to 118.5 K (+1.37 %) |
Oct 26 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Option Exercise | A | 33.00 | 300,000 | 9,900,000 | 300,000 | |
Jul 20 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Option Exercise | A | 33.28 | 36,250 | 1,206,400 | 36,250 | |
Jul 17 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Global R&D, CSO | Option Exercise | M | 9.69 | 2,400 | 23,256 | 0 | |
Jul 17 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Global R&D, CSO | Sell | S | 32.88 | 2,400 | 78,912 | 116,874 | 119.3 K to 116.9 K (-2.01 %) |
Jul 17 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Global R&D, CSO | Buy | M | 9.69 | 2,400 | 23,256 | 119,274 | 116.9 K to 119.3 K (+2.05 %) |
Jun 16 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Global R&D, CSO | Option Exercise | M | 9.69 | 2,400 | 23,256 | 2,400 | |
Jun 16 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Global R&D, CSO | Sell | S | 31.02 | 2,400 | 74,448 | 116,874 | 119.3 K to 116.9 K (-2.01 %) |
Jun 16 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Global R&D, CSO | Buy | M | 9.69 | 2,400 | 23,256 | 119,274 | 116.9 K to 119.3 K (+2.05 %) |
May 19 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Global R&D, CSO | Option Exercise | M | 9.69 | 2,400 | 23,256 | 4,800 | |
May 19 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Global R&D, CSO | Sell | S | 28.56 | 2,400 | 68,544 | 116,874 | 119.3 K to 116.9 K (-2.01 %) |
May 19 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Global R&D, CSO | Buy | M | 9.69 | 2,400 | 23,256 | 119,274 | 116.9 K to 119.3 K (+2.05 %) |
May 11 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP, Global R&D, CS ... | Sell | S | 28.94 | 12,796 | 370,316 | 116,796 | 129.6 K to 116.8 K (-9.87 %) |
Apr 16 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Option Exercise | M | 9.69 | 2,400 | 23,256 | 7,200 | |
Apr 16 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 26.98 | 2,400 | 64,752 | 129,670 | 132.1 K to 129.7 K (-1.82 %) |
Apr 16 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Buy | M | 9.69 | 2,400 | 23,256 | 132,070 | 129.7 K to 132.1 K (+1.85 %) |
Mar 17 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Option Exercise | M | 9.69 | 2,400 | 23,256 | 9,600 | |
Mar 17 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 28.98 | 1,000 | 28,980 | 97,356 | 98.4 K to 97.4 K (-1.02 %) |
Mar 17 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 28.05 | 1,400 | 39,270 | 98,356 | 99.8 K to 98.4 K (-1.40 %) |
Mar 17 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Buy | M | 9.69 | 2,400 | 23,256 | 99,756 | 97.4 K to 99.8 K (+2.47 %) |
Feb 19 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Option Exercise | M | 9.69 | 2,400 | 23,256 | 12,000 | |
Feb 19 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 32.88 | 2,400 | 78,912 | 97,356 | 99.8 K to 97.4 K (-2.41 %) |
Feb 19 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Buy | M | 9.69 | 2,400 | 23,256 | 99,756 | 97.4 K to 99.8 K (+2.47 %) |
Feb 06 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Option Exercise | A | 33.55 | 54,375 | 1,824,281 | 54,375 | |
Feb 06 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Grant | A | 0.01 | 12,084 | 121 | 97,356 | 85.3 K to 97.4 K (+14.17 %) |
Feb 06 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 34.07 | 218 | 7,427 | 85,272 | 85.5 K to 85.3 K (-0.26 %) |
Feb 06 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 33.55 | 900 | 30,195 | 85,490 | 86.4 K to 85.5 K (-1.04 %) |
Jan 16 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Option Exercise | M | 9.07 | 2,400 | 21,768 | 0 | |
Jan 16 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 29.63 | 2,400 | 71,112 | 86,390 | 88.8 K to 86.4 K (-2.70 %) |
Jan 16 2009 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Buy | M | 9.07 | 2,400 | 21,768 | 88,790 | 86.4 K to 88.8 K (+2.78 %) |
Dec 16 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Option Exercise | M | 9.07 | 2,400 | 21,768 | 2,400 | |
Dec 16 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 25.81 | 2,400 | 61,944 | 86,390 | 88.8 K to 86.4 K (-2.70 %) |
Dec 16 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Buy | M | 9.07 | 2,400 | 21,768 | 88,790 | 86.4 K to 88.8 K (+2.78 %) |
Nov 19 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Option Exercise | M | 9.07 | 2,400 | 21,768 | 4,800 | |
Nov 19 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 27.14 | 2,400 | 65,136 | 86,390 | 88.8 K to 86.4 K (-2.70 %) |
Nov 19 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Buy | M | 9.07 | 2,400 | 21,768 | 88,790 | 86.4 K to 88.8 K (+2.78 %) |
Oct 16 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Option Exercise | M | 9.07 | 2,400 | 21,768 | 7,200 | |
Oct 16 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 27.74 | 480 | 13,315 | 86,390 | 86.9 K to 86.4 K (-0.55 %) |
Oct 16 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 26.84 | 1,200 | 32,208 | 86,870 | 88.1 K to 86.9 K (-1.36 %) |
Oct 16 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 25.73 | 720 | 18,526 | 88,070 | 88.8 K to 88.1 K (-0.81 %) |
Oct 16 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Buy | M | 9.07 | 2,400 | 21,768 | 88,790 | 86.4 K to 88.8 K (+2.78 %) |
Sep 19 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Option Exercise | M | 9.07 | 2,400 | 21,768 | 9,600 | |
Sep 19 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 27.94 | 2,400 | 67,056 | 86,390 | 88.8 K to 86.4 K (-2.70 %) |
Sep 19 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Buy | M | 9.07 | 2,400 | 21,768 | 88,790 | 86.4 K to 88.8 K (+2.78 %) |
Jul 25 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Option Exercise | A | 32.16 | 36,250 | 1,165,800 | 36,250 | |
Jul 17 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Option Exercise | M | 9.07 | 2,400 | 21,768 | 12,000 | |
Jul 17 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 32.21 | 1,200 | 38,652 | 86,390 | 87.6 K to 86.4 K (-1.37 %) |
Jul 17 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 32.59 | 1,200 | 39,108 | 87,590 | 88.8 K to 87.6 K (-1.35 %) |
Jul 17 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Buy | M | 9.07 | 2,400 | 21,768 | 88,790 | 86.4 K to 88.8 K (+2.78 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 27.37 | 200 | 5,474 | 86,390 | 86.6 K to 86.4 K (-0.23 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 27.19 | 200 | 5,438 | 86,590 | 86.8 K to 86.6 K (-0.23 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 27.16 | 100 | 2,716 | 86,790 | 86.9 K to 86.8 K (-0.12 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 27.15 | 100 | 2,715 | 86,890 | 87 K to 86.9 K (-0.11 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 27.11 | 200 | 5,422 | 86,990 | 87.2 K to 87 K (-0.23 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 27.09 | 100 | 2,709 | 87,190 | 87.3 K to 87.2 K (-0.11 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 27.05 | 102 | 2,759 | 87,290 | 87.4 K to 87.3 K (-0.12 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 27.04 | 105 | 2,839 | 87,392 | 87.5 K to 87.4 K (-0.12 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 27.03 | 34 | 919 | 87,497 | 87.5 K to 87.5 K (-0.04 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 27.01 | 300 | 8,103 | 87,531 | 87.8 K to 87.5 K (-0.34 %) |
May 15 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Sell | S | 27.00 | 100 | 2,700 | 87,831 | 87.9 K to 87.8 K (-0.11 %) |
Feb 11 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Option Exercise | A | 18.93 | 72,500 | 1,372,425 | 72,500 | |
Feb 11 2008 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Grant | A | 0.01 | 14,501 | 145 | 87,931 | 73.4 K to 87.9 K (+19.75 %) |
Jul 16 2007 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | CSO&EVP Drug Innov& ... | Option Exercise | A | 28.84 | 36,250 | 1,045,450 | 36,250 | |
May 08 2007 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | CSO&EVP Drug Innov& ... | Sell | S | 30.59 | 11,401 | 348,757 | 73,430 | 84.8 K to 73.4 K (-13.44 %) |
Jan 26 2007 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Option Exercise | A | 36.30 | 54,375 | 1,973,813 | 54,375 | |
Jan 26 2007 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Grant | A | 0.01 | 20,000 | 200 | 84,831 | 64.8 K to 84.8 K (+30.85 %) |
Jan 26 2007 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Innov.& Re ... | Grant | A | 0.01 | 12,084 | 121 | 64,831 | 52.7 K to 64.8 K (+22.91 %) |
Dec 20 2006 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | CSO&EVP Drug Innov& ... | Sell | S | 38.00 | 165 | 6,270 | 52,747 | 52.9 K to 52.7 K (-0.31 %) |
Nov 21 2006 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | CSO&EVP Drug Innov& ... | Sell | S | 45.00 | 32,314 | 1,454,130 | 52,912 | 85.2 K to 52.9 K (-37.92 %) |
Nov 17 2006 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | CSO&EVP Drug Innov& ... | Option Exercise | D | 16.32 | 17,686 | 288,636 | 392,864 | |
Nov 17 2006 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | CSO&EVP Drug Innov& ... | Sell | S | 45.00 | 17,686 | 795,870 | 85,226 | 102.9 K to 85.2 K (-17.19 %) |
Nov 17 2006 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | CSO&EVP Drug Innov& ... | Buy | M | 16.32 | 17,686 | 288,636 | 102,912 | 85.2 K to 102.9 K (+20.75 %) |
Jul 24 2006 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | CSO&EVP Drug Innov& ... | Option Exercise | A | 35.35 | 36,250 | 1,281,438 | 410,550 | |
Mar 21 2006 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | CSO & EVP Drug Inno ... | Sell | S | 40.00 | 305 | 12,200 | 85,226 | 85.5 K to 85.2 K (-0.36 %) |
Feb 06 2006 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Disc., Inn ... | Option Exercise | A | 35.64 | 73,500 | 2,619,540 | 374,300 | |
Feb 06 2006 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | EVP Drug Disc., Inn ... | Grant | A | 0.01 | 12,200 | 122 | 85,531 | 73.3 K to 85.5 K (+16.64 %) |
Jan 09 2006 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | CSO & SVP Drug Disc ... | Sell | S | 30.78 | 1,213 | 37,336 | 73,331 | 74.5 K to 73.3 K (-1.63 %) |
Dec 21 2005 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | CSO & SVP Drug Disc ... | Sell | S | 27.84 | 1,496 | 41,649 | 74,554 | 76.1 K to 74.6 K (-1.97 %) |
Jul 22 2005 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | CSO & SVP Drug Disc ... | Option Exercise | A | 17.16 | 18,000 | 308,880 | 300,800 | |
Feb 07 2005 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | CSO & SVP Drug Disc ... | Option Exercise | A | 10.41 | 36,000 | 374,760 | 282,800 | |
Feb 07 2005 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | CSO & SVP Drug Disc ... | Grant | A | 0.01 | 7,200 | 72 | 76,040 | 68.8 K to 76 K (+10.46 %) |
Oct 12 2004 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | CSO & SVP Drug Disc ... | Option Exercise | A | 11.27 | 18,000 | 202,860 | 246,800 | |
May 10 2004 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | CSO & SVP Drug Disc ... | Grant | A | 0.01 | 65,000 | 650 | 68,840 | 3.8 K to 68.8 K (+1,692.71 %) |
Mar 19 2004 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | CSO & SVP Drug Disc ... | Option Exercise | A | 9.69 | 14,400 | 139,536 | 228,800 | |
Mar 19 2004 | VRTX | VERTEX PHARMACEUTI ... | MUELLER PETER | CSO & SVP Drug Disc ... | Grant | A | 0.01 | 1,920 | 19 | 3,840 | 1.9 K to 3.8 K (+100.00 %) |
Page: 1